Article ; Online: Response to: Ruxolitinib withdrawal due to the COVID-19.
2021 Volume 35, Issue 4, Page(s) 1219
| MeSH term(s) | COVID-19 ; Humans ; Neoplasms ; Nitriles ; Pyrazoles/adverse effects ; Pyrimidines ; SARS-CoV-2 | |||||
|---|---|---|---|---|---|---|
| Chemical Substances | Nitriles ; Pyrazoles ; Pyrimidines ; ruxolitinib (82S8X8XX8H) | |||||
| Language | English | |||||
| Publishing date | 2021-02-25 | |||||
| Publishing country | England | |||||
| Document type | Letter ; Comment | |||||
| ZDB-ID | 807030-1 | |||||
| ISSN | 1476-5551 ; 0887-6924 | |||||
| ISSN (online) | 1476-5551 | |||||
| ISSN | 0887-6924 | |||||
| DOI | 10.1038/s41375-021-01187-4 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 2295: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.